GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Progen Co Ltd (XKRX:296160) » Definitions » Accumulated Depreciation

Progen Co (XKRX:296160) Accumulated Depreciation : ₩-3,375.8 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Progen Co Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Progen Co's quarterly accumulated depreciation declined from . 20 (₩0.0 Mil) to Dec. 2023 (₩-2,401.5 Mil) but then increased from Dec. 2023 (₩-2,401.5 Mil) to Dec. 2024 (₩-3,375.8 Mil).

Progen Co's annual accumulated depreciation declined from . 20 (₩0.0 Mil) to Dec. 2023 (₩-2,401.5 Mil) but then increased from Dec. 2023 (₩-2,401.5 Mil) to Dec. 2024 (₩-3,375.8 Mil).


Progen Co Accumulated Depreciation Historical Data

The historical data trend for Progen Co's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Progen Co Accumulated Depreciation Chart

Progen Co Annual Data
Trend Dec23 Dec24
Accumulated Depreciation
-2,401.49 -3,375.82

Progen Co Semi-Annual Data
Dec23 Dec24
Accumulated Depreciation -2,401.49 -3,375.82

Progen Co Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.


Progen Co Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Progen Co's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.


Progen Co Business Description

Traded in Other Exchanges
N/A
Address
172 Magokjungang-ro, 7th Floor, Bio Innovation Park, Gangseo-gu, Seoul, KOR
Progen Co Ltd is an R&D focused biopharmaceutical development venture. It is engaged in developing metabolic disease treatments, immune disease treatments, and immune anti cancer drugs using its immunology based drug development know how, and is focusing on developing inventive drugs through domestic and international open innovation.

Progen Co Headlines

No Headlines